Issue link: http://catalog.e-digitaleditions.com/i/275023
42 control over financial reporting did not include the internal controls of Trauson Holdings Company Limited and MAKO Surgical Corp., which are included in the December 31, 2013 consolidated financial statements of Stryker Corporation and subsidiaries and constituted 2.3% and (0.2%) of total assets and shareholders' equity, respectively, as of December 31, 2013 and 0.7% and (3.2%) of revenues and net earnings, respectively, for the year then ended. Our audit of internal control over financial reporting of Stryker Corporation and subsidiaries also did not include an evaluation of the internal control over financial reporting of Trauson Holdings Company Limited and MAKO Surgical Corp. In our opinion, Stryker Corporation and subsidiaries maintained, in all material respects, effective internal control over financial reporting as of December 31, 2013, based on the COSO criteria. We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States), the consolidated balance sheets of Stryker Corporation and subsidiaries as of December 31, 2013 and 2012 and the related consolidated statements of earnings and comprehensive income, shareholders' equity and cash flows for each of the three years in the period ended December 31, 2013 of Stryker Corporation and subsidiaries, and our report dated February 13, 2014 expressed an unqualified opinion thereon. /s/ ERNST & YOUNG LLP Grand Rapids, Michigan February 13, 2014 ITEM 9B. OTHER INFORMATION. As previously announced, effective as of the filing of this Annual Report on Form 10-K, Tony M. McKinney resigned his position as Vice President and Chief Accounting Officer to accept another position with the Company. From and after the date of this filing, William E. Berry Jr., the Company's Vice President and Corporate Controller, will, as part of his regular duties and responsibilities, oversee the Company's accounting policies and function and serve as the Company's principal accounting officer. PART III ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE. Information regarding our directors and certain corporate governance and other matters appearing under the captions "Information About the Board of Directors and Corporate Governance Matters," "Proposal 1—Election of Directors," "Information About the Board of Directors and Corporate Governance Matters— Board Committees—Audit Committee" and "Additional Information—Section 16 (a) Beneficial Ownership Reporting Compliance" in the 2014 proxy statement is incorporated herein by reference. The names and ages of our executive officers as of January 31, 2014, the positions they held on that date and the year they first became an executive officer are: Name Age Position First Became an Executive Officer Kevin A. Lobo 48 President and Chief Executive Officer 2011 Steven P. Benscoter 46 Vice President, Human Resources 2012 Scott P. Bruder, MD, PhD 51 Vice President, Chief Medical and Scientific Officer 2013 Lonny J. Carpenter 52 Group President, Global Quality and Operations 2008 David K. Floyd 53 Group President, Orthopaedics 2012 Curtis E. Hall 57 Chief Legal Officer 2004 William R. Jellison 56 Vice President and Chief Financial Officer 2013 Tony M. McKinney 44 Vice President, Chief Accounting Officer 2008 Katherine A. Owen 43 Vice President, Strategy and Investor Relations 2007 Timothy J. Scannell 49 Group President, MedSurg and Neurotechnology 2008 Ramesh Subrahmanian 52 Group President, International 2011 Each of our executive officers was elected by our Board of Directors to serve in the office indicated until the first meeting of the Board of Directors following the annual meeting of shareholders in 2014 or until a successor is chosen and qualified or until his or her resignation or removal. Each of our executive officers has held the position above or has served Stryker in various executive or administrative capacities for at least five years, except for Mr. Lobo, Mr. Jellison, Dr. Bruder, Mr. Subrahmanian and Mr. Floyd. Prior to joining Stryker in April 2011, Mr. Lobo held a variety of senior level leadership roles for the previous nine years at Johnson & Johnson, most recently as Worldwide President of Ethicon Endo-Surgery. Prior to joining Stryker in April 2013, Mr. Jellison held a variety of senior level leadership roles for the previous 15 years at Dentsply International, the world's largest manufacturer of professional dental products, most recently as Senior Vice President and Chief Financial Officer. Prior to joining Stryker in January 2013, Dr. Bruder was Chief Science and Technology Officer for the previous five years with Becton, Dickinson and Company. Prior to joining Stryker in September 2011, Mr. Subrahmanian held a variety of senior level leadership roles for the previous five years with Merck & Co. Inc., most recently as